AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $38,000 | -42.4% | 16,599 | -27.5% | 0.00% | – |
| Q3 2021 | $66,000 | -35.3% | 22,905 | -15.1% | 0.00% | – |
| Q2 2021 | $102,000 | +12.1% | 26,963 | 0.0% | 0.00% | – |
| Q1 2021 | $91,000 | +26.4% | 26,963 | +5.5% | 0.00% | – |
| Q4 2020 | $72,000 | -60.7% | 25,552 | -64.9% | 0.00% | -100.0% |
| Q3 2020 | $183,000 | -78.8% | 72,802 | +14.6% | 0.00% | -75.0% |
| Q2 2020 | $863,000 | +75.8% | 63,550 | -1.9% | 0.00% | +33.3% |
| Q1 2020 | $491,000 | +20.0% | 64,793 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $409,000 | +42.0% | 64,793 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $288,000 | -21.1% | 73,401 | -2.7% | 0.00% | 0.0% |
| Q2 2019 | $365,000 | -40.9% | 75,401 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $618,000 | +60.5% | 75,401 | +8.4% | 0.00% | +33.3% |
| Q4 2018 | $385,000 | – | 69,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |